Matt Riley

Matt Riley is an experienced professional in investor relations and corporate communications, currently serving as Senior Director of Investor Relations at both Lucid Diagnostics and PAVmed Inc. Since 2018, Matt has led investor relations at Agile Therapeutics, which was acquired by Insud Pharma, S.L. Past roles include Product Manager at LevLane Advertising and Director of Client Development in Life Sciences at Agile Therapeutics. Additional experience includes positions at Digitas Health LifeBrands, PulseCX, and EMC Outdoor. Matt holds a Bachelor of Arts in Advertising from Penn State University, an MBA in Marketing from Drexel University's LeBow College of Business, and a Mini-MBA from Villanova University.